- Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.N Engl J Med, 2018, 378(10): 973-973.
- Development of a clinicomolecular risk stratification system for nonmetastatic nasopharyngeal carcinoma using Epstein-Barr virus DNA and TNM stage: A "Big data" analysis of 9,160 endemic cases.Chen, Fo-Ping; Zhou, Guan-Qun; Luo, Ying-Shan; Tan, Kuan Rui Lloyd; Tan, Sze Huey; Zheng, Yu; Lin, Li; Guo, Ying; Ma, Jun; Chua, Melvin L. K.; Sun, YingAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2019-05-31 To 2019-06-04.
- Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein–Barr virus DNA level and tumor response to palliative chemotherapyXue Song Sun; Li Ting Liu; Sai Lan Liu; Shan Shan Guo; Yue Feng Wen; Hao Jun Xie; Qing Nan Tang; Yu Jing Liang; Xiao Yun Li; Jin Jie Yan; Jun Ma; Qiu Yan Chen; Lin Quan Tang; Hai Qiang Mai2019.
会议论文
Longitudinal circulating Epstein-Barr virus DNA response to induction chemotherapy and chemo-radiotherapy to identify biological phenotypes in EBV-associated nasopharynx of head and neck cancer.
18阅读
